SCHEMBL27318924

SCHEMBL27318924

Nc1ncccc1-c1nc(NCCc2c[nH]c3ccccc23)c2ncsc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
GBA1 P04062 1/20 0.47
CCNT1 O60563 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CDK9 P50750 1/20 0.45
NSD2 O96028 1/20 0.44
MAPK1 P28482 2/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
GFER P55789 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PDPK1 O15530 1/20 0.42
RPS6KB1 P23443 1/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30867200 1.00 NQO1 (0.48) NQO1NPC1RAB9AGBA1CCNT1
SCHEMBL30867136 0.89 NQO1 (0.48) NQO1NPC1RAB9AGBA1CCNT1
SCHEMBL27318685 0.89 NQO1 (0.48) NQO1NPC1RAB9AGBA1CCNT1
SCHEMBL30867152 0.85 SSTR2 (0.39) NQO1NPC1RAB9ACCNT1CCNA2
SCHEMBL27319084 0.85 SSTR2 (0.39) NQO1NPC1RAB9ACCNT1CCNA2
SCHEMBL30867175 0.84 NQO1 (0.46) NQO1NPC1RAB9AGBA1CCNT1
SCHEMBL27318674 0.84 NQO1 (0.46) NQO1NPC1RAB9AGBA1CCNT1
SCHEMBL30867197 0.83 GBA1 (0.69) NPC1RAB9AGBA1CCNT1CCNA2
SCHEMBL30867186 0.83 GBA1 (0.55) NQO1NPC1RAB9AGBA1CCNT1
SCHEMBL27319390 0.83 GBA1 (0.55) NQO1NPC1RAB9AGBA1CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024076300-A1 COMPOUNDS USEFUL IN MODULATION OF AHR SIGNALLING JAGUAHR THERAPEUTICS PTE LTD (SG) 2024-04-11 WO disclosed